Results 191 to 200 of about 3,729,717 (272)
Homicide and nitroglycerin: a case of drug interaction?
Examines the mysterious circumstances surrounding the death of a young woman in 1901 and the possibility that it was due to drinking nitroglycerin.
F. D. Di Carlo, L. C. Holmes
semanticscholar +5 more sources
Influence of formulating factors on drug safety of timed-release nitroglycerin tablets.
A peroral sandwich model tablet with timed release, containing proxyphylline and nitroglycerin, was developed. One layer of the tablet constituted the rapidly disintegrating and dissolving initial phase; the other, the depot phase, was in the form of an ...
W. Ritschel
semanticscholar +5 more sources
Nitroglycerin: new concepts about an old drug. [PDF]
Abstract Increasing evidence has profoundly challenged previously accepted concepts about the actions and clinical uses of nitroglycerin. Traditionally, use of this agent has been contraindicated in patients with acute myocardial infarction because of its hypotensive effects, and it has had no place in the therapeutic armamentarium of heart failure or
R. Helfant
semanticscholar +4 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nitroglycerin ameliorates liver injury and regulates adaptive immunity in mice
Drug Development Research, 2020This study aimed to assess the protective effect of nitroglycerin, a commonly used drug in cardiovascular diseases, on mice with acute liver injury induced by carbon tetrachloride (CCl4 ). The mice were randomly divided into three groups: control, CCl4 ,
Jian-he Gan, Zhong-hua Lu
exaly +2 more sources
Archives of Internal Medicine, 1990
The purpose of this randomized crossover study was to determine whether nitroglycerin interacts with heparin in terms of its anticoagulative properties as determined by activated partial thromboplastin time and thrombin time.
V. Bode+3 more
semanticscholar +4 more sources
The purpose of this randomized crossover study was to determine whether nitroglycerin interacts with heparin in terms of its anticoagulative properties as determined by activated partial thromboplastin time and thrombin time.
V. Bode+3 more
semanticscholar +4 more sources
Recent reports suggest that intermittent nitroglycerin (NTG) treatment, incorporating a daily nitrate-free interval, can avoid the tolerance associated with continuous NTG therapy. This study has investigated whether an in vitro model of NTG tolerance could be used to examine the mechanisms of tolerance avoidance (by intermittent NTG exposure) and ...
E. Kowaluk, K. Hough, H. Fung
semanticscholar +5 more sources
The medical treatment of angina pectoris IV. Nitroglycerin as an antianginal drug
W. Aronow, W. Aronow
semanticscholar +5 more sources
Adhesive Matrix Type Transdermal Drug Delivery System for Nitroglycerin
Drug Development and Industrial Pharmacy, 1994The kinetics of release of nitroglycerin from adhesive matrix type patches was studied. At a high drug to adhesive ratio the patch consisted of nitroglycerin in part dispersed as droplets in the adhesive and in part dissolved in the adhesive.
R. M. Pai+3 more
semanticscholar +3 more sources
Relief of coronary artery spasm by nitroglycerin: time-dependent variability in drug action.
Catheterization and Cardiovascular Diagnosis, 1978The arteriographic distinction between a fixed atheromatous obstruction and localized vasospasm in the coronary artery is often decided by the response of the lesion to nitroglycerin.
E. Fallen+3 more
semanticscholar +4 more sources
Assessment of the Drug Interaction between Intravenous Nitroglycerin and Heparin
Annals of Pharmacotherapy, 1992OBJECTIVE: To assess whether a clinically significant interaction occurs between heparin and nitroglycerin (NTG). METHODOLOGY: Activated partial thromboplastin time (APTT) was measured in patients with unstable angina who were stabilized on intravenous NTG and heparin just prior to weaning the NTG infusion, and one and four hours after stopping the NTG.
E. R. Gonzalez+3 more
semanticscholar +4 more sources